Citations

Showing 10 of 108094 citations.

Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT‐1/‐2 studies
Cartin‐Ceba, Rodrigo , Halank, Michael , Ghofrani, Hossein‐Ardeschir, Humbert, Marc , Mattson, John P., Fritsch, Arno, Krowka, Michael J. , Ghofrani, Hossein Ardeschir , Krowka, Michael, Ghofrani, Hossein Ardeschir

Mayo Clinic

Pulmonary Circulation | March 22, 2018 | Volume: 8 | Issue: 2 | Pages: 1-4

10.1177/2045894018769305 | PMID 29565224 Get It

In patients with portopulmonary hypertension (n = 13) included in the 12‐week randomized placebo‐controlled PATENT‐1 trial, riociguat was well tolerated and improved 6‐min walking distance (6MWD), World Health Organization functional class (WHO FC), and other efficacy parameters; 6MWD and WHO FC improvements were sustained over two years in the open‐label extension, PATENT‐2.
A Sarcoidlike Reaction Mimicking Metastatic Malignancy in a Patient With Melanoma Treated With Pembrolizumab
Wesselius, Lewis , DeLeon, Thomas, Wesselius, Lewis J, DeLeon, Thomas T, Gotway, Michael B.

Mayo Clinic

American Journal of Roentgenology | March 22, 2018 | Volume: 210 | Issue: 4 | Pages: W183-W184

10.2214/ajr.17.19144 | PMID 29565201 Get It

Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Five-Year Follow-up of a Prospective Randomized Trial
Recker, David P., Ilgenfritz, John, Saris, Daniël B.F. , Group, on behalf of the SUMMIT Extension Study, Brittberg, Mats , Group, on behalf of the SUMMIT Extension Study

Mayo Clinic

The American Journal of Sports Medicine | March 22, 2018 | Volume: 46 | Issue: 6 | Pages: 1343-1351

10.1177/0363546518756976 | PMID 29565642 Get It

Background: Matrix-based cell therapy improves surgical handling, increases patient comfort, and allows for expanded indications with better reliability within the knee joint. Five-year efficacy and safety of autologous cultured chondrocytes on porcine collagen membrane (MACI) versus microfracture for treating cartilage defects have not yet been reported from any randomized controlled clinical trial. Purpose: To examine the clinical efficacy and safety results at 5 years after treatment with MACI and compare these with the efficacy and safety of microfracture treatment for symptomatic cartilage defects of the knee. Study Design: Randomized controlled trial; Level of evidence, 1. Methods: This article describes the 5-year follow-up of the SUMMIT (Superiority of MACI Implant Versus Microfracture Treatment) clinical trial conducted at 14 study sites in Europe. All 144 patients who participated in SUMMIT were eligible to enroll; analyses of the 5-year data were performed with data from patients who signed informed consent and continued in the Extension study. Results: Of the 144 patients randomized in the SUMMIT trial, 128 signed informed consent and continued observation in the Extension study: 65 MACI (90.3%) and 63 microfracture (87.5%). The improvements in Knee injury and Osteoarthritis Outcome Score (KOOS) Pain and Function domains previously described were maintained over the 5-year follow-up. Five years after treatment, the improvement in MACI over microfracture in the co-primary endpoint of KOOS pain and function was maintained and was clinically and statistically significant ( P = .022). Improvements in activities of daily living remained statistically significantly better ( P = .007) in MACI patients, with quality of life and other symptoms remaining numerically higher in MACI patients but losing statistical significance relative to the results of the SUMMIT 2-year analysis. Magnetic resonance imaging (MRI) evaluation of structural repair was performed in 120 patients at year 5. As in the 2-year SUMMIT (MACI00206) results, the MRI evaluation showed improvement in defect filling for both treatments; however, no statistically significant differences were noted between treatment groups. Conclusion: Symptomatic cartilage knee defects 3 cm 2 or larger treated with MACI were clinically and statistically significantly improved at 5 years compared with microfracture treatment. No remarkable adverse events or safety issues were noted in this heterogeneous patient population.
Telemedicine Use for Movement Disorders: A Global Survey
Hassan, Anhar , Dorsey, E. Ray , Bloem, Bastiaan R. , Guttman, Mark, Pantelyat, Alexander , Galifianakis, Nicholas B. , Bajwa, Jawad A. , Gatto, Emilia , Cubo, Esther , Pantelyat, Alex , Goetz, Christopher G. , Tanner, Caroline M. , Mari, Zoltan K.

Mayo Clinic

Telemedicine and e-Health | March 22, 2018 | Volume: 24 | Issue: 12 | Pages: 979-992

10.1089/tmj.2017.0295 | PMID 29565764 Get It

Background: Telemedicine is increasingly used to care for patients with movement disorders, but data regarding its global use are limited. Introduction: To obtain baseline international data about telemedicine use among movement disorder clinicians. Methods: An online survey was sent to all 6,056 Movement Disorder Society members in 2015. Scope, reimbursement, and perceived quality of telemedicine were assessed. Results: There were 549 respondents (9.1% overall response rate) from 83 countries. Most (85.8%) were physicians, and most (70.9%) worked in an academic or university practice. Half of respondents ( n = 287, from 57 countries) used telemedicine for clinical care; activities included e-mail (63.2%), video visits (follow-up [39.7%] and new [35.2%]), and video-based education (35.2%). One hundred five respondents personally conducted video visits, most frequently to outpatient clinics (53.5%), patient homes (30.8%), and hospital inpatients (30.3%). The most common challenges were a limited neurological examination (58.9%) and technological difficulties (53.3%), and the most common benefits were reduced travel time (92.9%) and patient costs (60.1%). The most frequent reimbursements were none (39.0%), public insurance (24.5%), and patient payment (9.3%). Half of respondents planned to use telemedicine in the future, and three-quarters were interested in telemedicine education. Conclusions: More than 250 respondents around the world engage in telemedicine for movement disorders; most perceived benefit for patients, despite challenges and reimbursement for clinicians. Formal instruction on telemedicine is highly desired. Although the survey response was low and possibly biased to over represent those with telemedicine experience, the study provides baseline data for future comparison and to improve telemedicine delivery.
Networking Matters: A Social Network Analysis of the Association of Program Directors of Internal Medicine
Warm, Eric J. , Arora, Vineet M. , Chaudhry, Saima , Halvorsen, Andrew J. , Schauer, Daniel P. , Thomas, Kris G., McDonald, Furman S., Warm, Eric , Halvorsen, Andrew, Thomas, Kris

Mayo Clinic

Teaching and Learning in Medicine | March 22, 2018 | Volume: 30 | Issue: 4 | Pages: 415-422

10.1080/10401334.2018.1441715 | PMID 29565686 Get It

Vascular Tumors in Infants: Case Report and Review of Clinical, Histopathologic, and Immunohistochemical Characteristics of Infantile Hemangioma, Pyogenic Granuloma, Noninvoluting Congenital Hemangioma, Tufted Angioma, and Kaposiform Hemangioendothelioma
Johnson, Emma F. , Tollefson, Megha M. , Fritchie, Karen , Gibson, Lawrence E. , Davis, Dawn M., Davis, Dawn Marie R.

Mayo Clinic

The American Journal of Dermatopathology | March 22, 2018 | Volume: 40 | Issue: 4 | Pages: 231-239

10.1097/dad.0000000000000983 | PMID 29561329 Get It

Abstract: Vascular tumors in infants present a diagnostic and treatment dilemma for both clinicians and pathologists. Infantile hemangioma, the most common vascular tumor in infants, can be confused for other less common vascular tumors in infants. Correct and timely diagnosis is important, as some vascular tumors can be associated with life-threatening coagulopathy. We present the cases of 5 vascular tumors that have clinical and histologic overlap: infantile hemangioma, pyogenic granuloma, noninvoluting congenital hemangioma, tufted angioma, and kaposiform hemangioendothelioma. Typical clinical and histopathologic features of each lesion are summarized. We review the utility and characteristic immunohistochemistry including CD31, CD34, GLUT-1, D2-40, LYVE-1, Prox-1, and WT-1. Collaboration between the clinician and the dermatopathologist correlating the clinical history and histopathologic features can lead to the correct diagnosis, whereas the utility of immunohistochemistry remains in question.
The Lifecycle of an Evidence-Based Laboratory Practice Guideline: Origin, Update, Affirmation, and Impact!
Nakhleh, Raouf E. , Fitzgibbons, Patrick L. , Nowak, Jan A. , Najarían, Robert M., Keren, David F. , Colgan, Terence J. , Fatheree, Lisa A., Nakhleh, Raouf, Colasacco, Carol

Mayo Clinic

Archives of Pathology & Laboratory Medicine | March 22, 2018 | Volume: 142 | Issue: 4 | Pages: 438-440

10.5858/arpa.2017-0401-ed | PMID 29565208 Get It

FUNCTIONAL AND KINEMATIC ANALYSIS OF A WRIST RADIAL HEMIARTHROPLASTY DESIGN
Hooke, Alexander W. , Wagner, Eric R. , Pettersson, Kurt, Fischer, Per , Rizzo, Marco , Wagner, Eric R

Mayo Clinic

Journal of Musculoskeletal Research | March 22, 2018 | Volume: 21 | Issue: 01 | Pages: 1850005

10.1142/s0218957718500057 Get It

Purpose: A biomechanical functional assessment was performed on a newly designed wrist hemiarthroplasty implant with aimed to identifying differences between the native wrist and wrist following the hemiarthroplasty procedure with [Formula: see text] and without a proximal row carpectomy (Hemi). Methods: Six cadaveric wrists were mounted on a custom testing fixture and underwent a series of functional tests to investigate differences in range of motion, muscles moment arms, and axis of rotation between the intact and post-operative wrists. The tested movements included manually-driven flexion-extension, radial-ulnar deviation, dart throwers motion, and circumduction. Results: The only significant change in range of motion was a decrease in flexion between the intact [Formula: see text] and both the Hemi [Formula: see text] and [Formula: see text] [Formula: see text] conditions. Minor differences in the mean position and variability of the axis of rotation’s piercing point were identified. A statistically significant decrease in the flexion moment arm of the flexor carpi radialis was identified between the intact ([Formula: see text][Formula: see text]mm) and [Formula: see text] ([Formula: see text][Formula: see text]mm) conditions. Statistically significant decreases were also identified in the radial deviation moment arms of the extensor carpi radialis brevis’ between the intact ([Formula: see text][Formula: see text]mm) and [Formula: see text] ([Formula: see text][Formula: see text]mm) conditions and the flexor carpi radialis’ between the intact ([Formula: see text][Formula: see text]mm) and Hemi ([Formula: see text][Formula: see text]mm) conditions as well as in the ulnar deviation moment arm of the extensor carpi ulnaris between the intact ([Formula: see text][Formula: see text]mm) and Hemi ([Formula: see text][Formula: see text]mm) conditions. Conclusions: While some statistically significant functional changes were identified between the native and hemiarthroplasty wrist, the findings suggest that post-operative function is equally acceptable in hemiarthroplasty with and without resection of the proximal carpal row.
Localization and functional consequences of a direct interaction between TRIOBP-1 and hERG proteins in the heart
Jones, David K., Johnson, Ashley , Roti, Elon C. Roti , Uelmen, Rebecca , Ayers, Rebecca A., Baczkó, István , Tester, David J. , Ackerman, Michael J. , Robertson, Gail A. , Roti Roti, Elon C , Uelmen, Rebecca , Robertson, Gail A , Jones, David K., Liu, Fang , Trudeau, Matthew C.

Mayo Clinic

Journal of Cell Science | March 22, 2018 | Volume: 131 | Issue: 6 | Pages: No page available

10.1242/jcs.206730 | PMID 29507111 Get It

ABSTRACT Reduced levels of the cardiac human (h)ERG ion channel protein and the corresponding repolarizing current IKr can cause arrhythmia and sudden cardiac death, but the underlying cellular mechanisms controlling hERG surface expression are not well understood. Here, we identified TRIOBP-1, an F-actin-binding protein previously associated with actin polymerization, as a putative hERG-interacting protein in a yeast-two hybrid screen of a cardiac library. We corroborated this interaction by performing Förster resonance energy transfer (FRET) in HEK293 cells and co-immunoprecipitation in HEK293 cells and native cardiac tissue. TRIOBP-1 overexpression reduced hERG surface expression and current density, whereas reducing TRIOBP-1 expression via shRNA knockdown resulted in increased hERG protein levels. Immunolabeling in rat cardiomyocytes showed that native TRIOBP-1 colocalized predominantly with myosin-binding protein C and secondarily with rat ERG. In human stem cell-derived cardiomyocytes, TRIOBP-1 overexpression caused intracellular co-sequestration of hERG signal, reduced native IKr and disrupted action potential repolarization. Ca2+ currents were also somewhat reduced and cell capacitance was increased. These findings establish that TRIOBP-1 interacts directly with hERG and can affect protein levels, IKr magnitude and cardiac membrane excitability.
Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome
Thouvenot, Éric , Hinsinger, Geoffrey, Dematteï, Christophe , Uygunoğlu, Uğur , Castelnovo, Giovanni, Pittion‐Vouyovitch, S., Okuda, Darin T. , Kantarci, Orhun H. , Pelletier, Daniel , Lehmann, Sylvain , Marin, Philippe , Sıva, Aksel , Lebrun‐Frénay, Christine , Lebrun‐Frénay, Christine , Siva, Aksel , Thouvenot, Eric , Okuda, Darin T , Lehmann, Sylvain

Mayo Clinic

Multiple Sclerosis Journal | March 22, 2018 | Volume: 25 | Issue: 5 | Pages: 669-677

10.1177/1352458518767043 | PMID 29564952 Get It

Background: Younger age, male sex and presence of spinal cord lesion(s) increase the risk of conversion from radiologically isolated syndrome (RIS) to relapsing-remitting multiple sclerosis (RRMS). Elevated cerebrospinal fluid (CSF) chitinase-3-like protein 1 (CHI3L1) levels predict conversion from clinically isolated syndrome (CIS) to RRMS. Objective: To evaluate the prognostic value of CSF CHI3L1 in RIS patients for conversion to RRMS. Methods: We compared CSF CHI3L1 concentrations in RIS, CIS, RRMS and symptomatic controls (SCs). We analysed the influence of epidemiological, radiological and CSF parameters on the risk of clinical event. Results: A total of 211 patients (71 RIS, 48 CIS, 50 RRMS and 42 SC) were included. CSF CHI3L1 levels were lower in RIS than in RRMS and higher in RIS with positive CSF versus negative CSF and SC. The presence of at least one spinal cord lesion was the only independent predictor of faster conversion to RRMS. Association of high CSF CHI3L1 levels, positive CSF (presence of oligoclonal bands and/or an elevated IgG index) or four Barkhof criteria with any spinal cord lesion showed a tendency for reduced mean conversion time. Conclusion: CSF CHI3L1 correlates with positive CSF but is not an independent predictor of the risk of conversion from RIS to RRMS.